|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 EUR | +1.25% |
|
-1.46% | +7.16% |
| Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
| Feb. 14 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Biohit Oyj appointed Jussi Sorvo as Chief Financial Officer starting September 7th, 2022. He will also be responsible for HR and ICT functions. Sorvo will report to CEO Jussi Hahtela.
Sorvo has worked at Biohit as a business controller since June 2021. Previously he has worked at PwC as an auditor and in data-analytics utilization and other reporting development projects.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.16% | 32.72M | |
| +7.13% | 7.91B | |
| -3.15% | 4.66B | |
| -9.18% | 2.84B | |
| +1.11% | 2.03B | |
| -26.56% | 1.12B | |
| -11.09% | 816M | |
| -13.49% | 755M | |
| -22.71% | 759M | |
| -56.85% | 682M |
BIOHIT OYJ 
